A detailed history of Susquehanna International Group, LLP transactions in Landec Corp \Ca\ stock. As of the latest transaction made, Susquehanna International Group, LLP holds 17,844 shares of LNDC stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares
17,844
Previous 167,095 89.32%
Holding current value
$0
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 15, 2024

SELL
N/A
-149,251 Reduced 89.32%
17,844 $0
Q1 2024

May 07, 2024

SELL
N/A
-58,872 Reduced 26.05%
167,095 $0
Q4 2023

Feb 14, 2024

SELL
N/A
-109,197 Reduced 32.58%
225,967 $0
Q3 2023

Nov 14, 2023

BUY
N/A
8,149 Added 2.49%
335,164 $0
Q2 2023

Aug 11, 2023

BUY
N/A
274,103 Added 518.04%
327,015 $0
Q1 2023

May 16, 2023

BUY
N/A
34,585 Added 188.71%
52,912 $0
Q4 2022

Feb 14, 2023

BUY
$0.0 - $9.95 $0 - $182,353
18,327 New
18,327 $0
Q2 2022

Aug 15, 2022

SELL
$8.84 - $11.64 $89,213 - $117,470
-10,092 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$10.07 - $11.93 $101,626 - $120,397
10,092 New
10,092 $117,000
Q3 2021

Nov 15, 2021

SELL
$9.22 - $12.44 $215,794 - $291,158
-23,405 Closed
0 $0
Q2 2021

Aug 11, 2021

BUY
$9.91 - $12.78 $231,943 - $299,115
23,405 New
23,405 $263,000
Q4 2019

Feb 14, 2020

SELL
$9.09 - $11.89 $157,147 - $205,554
-17,288 Closed
0 $0
Q3 2019

Nov 14, 2019

BUY
$9.66 - $12.36 $57,264 - $73,270
5,928 Added 52.18%
17,288 $188,000
Q2 2019

Aug 16, 2019

BUY
$9.32 - $12.98 $105,875 - $147,452
11,360 New
11,360 $106,000
Q3 2018

Nov 14, 2018

SELL
$12.65 - $15.15 $145,715 - $174,512
-11,519 Closed
0 $0
Q2 2018

Aug 14, 2018

SELL
$13.05 - $15.45 $213,106 - $252,298
-16,330 Reduced 58.64%
11,519 $172,000
Q1 2018

May 15, 2018

BUY
$12.0 - $14.45 $334,188 - $402,418
27,849 New
27,849 $363,000

Others Institutions Holding LNDC

About LANDEC CORP \CA\


  • Ticker LNDC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 29,595,600
  • Description
  • Landec Corporation operates as a diversified health and wellness company. The company manufactures pharmaceutical-grade sodium hyaluronate (HA)-based biomaterials for primary use in the ophthalmic and orthopedic markets. It also provides product development services to its partners for HA-based, as well as non-HA based, aseptically formulated, a...
More about LNDC
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.